Background. The mechanism by which anaesthetic agents produce general anaesthesia is not yet fully understood. Retraction of neurites is an important function of individual neurones and neural plexuses during normal and pathological conditions, and it has been shown that such a retraction pathway exists in developing and mature neurones. We hypothesized that propofol decreases neuronal activity by causing retraction of neuronal neurites.
The underlying mechanisms by which diverse anaesthetic agents produce anaesthesia are not yet fully understood. 1 The normal function of the nervous system depends on precise connections that wire individual neurones together into an orderly network. Selective retraction of newly formed axons occurs extensively in the developing nervous system to eliminate inappropriate axonal projections. 2 Hibernating mammals experience a temperature-dependent retraction of the neural microstructure throughout the brain, and recovery of this microstructure to fixed parameters is rapid and complete on return to euthermia. 3 Retraction is also an early response of axons to injury. 4 Recent investigations indicate that retraction is an active process mediated by alterations in actin filament structure and motor proteinbased force generation. 5 6 A main function of molecular motor proteins is axonal vesicular transport in neurones. It has been shown that many anaesthetic agents modulate synaptic transmission 7 and depress neurosecretion. 8 Propofol induces growth cone collapse and neurite retraction in chick explant culture. 9 We have previously reported that propofol causes a reorganization of actin to form ring structures in cultured rat neurones and glial cells. 10 In the present study, the effects of propofol on neurite morphology were observed, and the response dynamics were analysed using time-lapse light microscopy. dissected free. Cortical tissue was sieved through nylon mesh (80 mm) into Dulbecco's modified Eagle's medium high glucose (Sigma Chemical Co., St Louis, MO, USA), supplemented with glucose (30 mM), insulin (5 mg ml -1 ), glutamine (2 mM), penicillin (50 U ml -1 ), streptomycin (50 mg ml -1 ), and 20% fetal calf serum (FCS). The cells were cultured on poly-L-lysine-coated 25 mm f sterile coverslips at 378C in a humidified atmosphere of 95% air/ 5% CO 2 . After 24 h, the FCS concentration of the medium was changed to 10% and maintained at that level for 7 days. On the sixth day, 10 mM cytosine-1-b-D-arabinofuranoside was added to new 10% media for 24 h, to suppress growth of glial cells. Thereafter, the cultures received new medium containing 5% FCS every second day. The cells were used between days 14 and 35.
Microscopy
Cells used for microscopy (on 25 mm round coverslips) were placed in Petri dishes. Each cell culture was rinsed twice in Ca 2þ -containing medium (CCM) 12 before use. The dynamics of neurite morphology were observed before and after the addition of propofol. Cells were exposed to 0.02, 0.2, 2, and 20 mM propofol as the commercially available solution Diprivan w (10 mg ml
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; Astrazeneca Ltd, Cheshire, UK) or lipid vehicle as the commercially available solution Vasolipid (20 mg ml
; Braun, Melsungen, Germany). Time-lapse images were acquired as described below. Bicuculline (30 mM) (Sigma Chemical Co., St Louis, MO, USA) was added 10 min before exposure to propofol. Phalloidin (5 mM) (Sigma Chemical Co.) was added 10 min and blebbistatin (1 mM) (Calbiochem, EMD Biosciences, Inc., Darmstadt, Germany) 3 min before exposure to propofol. To observe reversibility, propofol was washed out from the culture media after 2 min exposure and the cells were observed for 20 min.
Coverslips with cell cultures were mounted in an RC-21B closed bath imaging chamber and observed by light microscopy using a Zeiss Axiovert 200 (Göttingen, Germany) inverted microscope equipped with an alpha Plan-Fluar 100Â/1.45 numerical aperture (NA) oil immersion objective (Carl Zeiss, Microimaging GmbH, Göttingen, Germany). Images were captured using a cooled charge-coupled device (CCD) AxioCam MRm (Carl Zeiss). The temperature in the cell culture was maintained at 378C using an objective heater (8Pecon GmbH, Erbach, Germany). A time-lapse series was initiated wherein cell images were obtained at 1 min intervals between 0 and 10 min. To visualize a thin trailing remnant and retraction bulb, differential interference contrast images of cells on a 378C heated stage were captured using a Zeiss Axiovert 135M equipped with a 100Â 1.3 NA objective and a ProgRes C10plus CCD camera (Jenoptik, Jena, Germany).
Data quantification and statistical analysis
Neurite retraction was calculated by subtracting the final length from the initial length. Neurite length was measured manually using Adobe PhotoShop 6.0 (Adobe Systems, San Jose, CA, USA) by an observer blinded to the image analysing. The retraction change of the neurite is presented as a proportion of the initial length. Overall significant differences between conditions were determined by two-way analysis of variance for repeated measurements (ANOVA). Post hoc comparisons were performed by the Bonferroni test for multiple comparisons. For propofol, experimental values are expressed as the mean (SD) of 14 independent measurements. In each measurement, one neurone was analysed. The cell cultures were obtained from a total of 5 litters. Concentration -response curves for neurite retraction were analysed (Prism 4.0 software, GraphPad Software, San Diego, CA, USA) by non-linear curve fitting [using the following equation: Y¼Bottomþ(Top2Bottom)/(1þ10 (log EC502X)ÂHillslope )] to obtain the negative logarithm of the propofol concentration that produced half ( pEC 50 ) of the maximal neurite retraction. All statistical analyses and graphing were done using Prism 4.0 software, and P-value of ,0.05 was considered statistically significant.
Results

Propofol-induced neurite retraction is time-dependent
To study the effects of clinically relevant concentrations of propofol on rat cortical neurites in vitro, we used timelapse light microscopy (Figs 1A, 2A, and 3A). The response dynamics were evaluated by measuring neurite retraction distance. This was compared with the initial length of the extended neurite which varied between 7 and 40 mm. Images of retracted neurites show that most of them are characterized by a retraction bulb and a thin trailing remnant ( Fig. 2A) .
To determine the time course of neurite retraction, we measured neurite length over 10 min after propofol application. Between 1 and 2 min after exposure to 20 mM propofol, neurites had retracted 16.1 (11.5)% and 21.1 (14.6)%, respectively [mean (SD)], P,0.01 compared with vehicle-exposed neurites that showed no change in length [22.6 (3.9)% and 2.0 (5.9)%, respectively] (Fig. 1B) . At 5 min post-exposure to 2 and 20 mM propofol, neurites had retracted 22.8 (10.5) and 34.2 (18), respectively, P,0.001 compared with vehicle-exposed neurites [25.8 (7.1) and 0.1 (11.4)]. Neurites continued to retract over time such that at 10 min post-propofol application neurite retraction was 34.9% (15.2) and 47.1% (16.8) for 2 and 20 mM, respectively. Vehicle-exposed neurites showed no change in length [25.9 (7.1) and 1.3 (13.4), respectively].
Propofol 0.02 and 0.2 mM concentrations [1.7 (8.2)% and 1.4 (12.8)% change, respectively] were ineffective. (At 0.2 mM, one of the neurones was excluded due to contractility of the whole cell which made measurement impossible.)
Propofol-induced neurite retraction was concentration-dependent
Propofol-induced neurite retraction was concentrationdependent. No response was seen at 0.02 and 0.2 mM. The EC 50 values at 2 and 10 min propofol exposure were 1.1 and 1.5 mM, respectively [ pEC 50 was 25.97 (0.28) and 25.8 (1.5)] (Fig. 2B) . These values agree well with the clinical EC 50 concentration for propofol (1.57 mM).
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Propofol-induced neurite retraction was reversible When 2 mM propofol was washed out 2 min after exposure, neurites continued to retract reaching a minimum length at 10 min. By 20 min, the neurites had returned to pretreatment length (Fig. 3A and B) . Propofol-induced retraction was not reversible after prolonged exposure (30 min) or exposure to 20 mM propofol.
Bicuculline, blebbistatin, and phalloidin inhibit propofol-induced retraction
To examine propofol cell signalling pathway(s), we applied pharmacological inhibitors to cultured neurones. The GABA A -receptor blocker bicuculline (30 mM) inhibited the propofol-mediated neurite retraction (Fig. 4) . It has been shown that axon retraction is dependent on an interaction between myosin and actin. 6 To confirm this, we applied the myosin II blocker, blebbistatin (1 mM), and the F-actin stabilizing agent, phalloidin (5 mM), both of which completely inhibited propofol-induced neurite retraction (Fig. 4) .
Discussion
We have examined the effect of the anaesthetic agent propofol on neurite retraction in vitro using rat cortical neurone cultures. Compared with vehicle-treated neurites, propofol caused a GABA A receptor (GABA A R)-mediated, concentration-dependent neurite retraction. The concentrations of propofol used in the cell cultures were clinically relevant and we found an EC 50 of 1.1 and 1.5 mM, after 2 and 10 min propofol exposure, which is very close to the anaesthetic EC 50 concentration of propofol (1.57 mM).
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The retraction is time-dependent and reversible. We could inhibit propofol-mediated neurite retraction by using the myosin II ATPase activity inhibitor blebbistatin, 14 which shows that retraction is a myosin II-dependent and active process. These findings support our hypothesis that propofol activates the GABA A R leading to an actin -myosin contraction. Treatment with propofol initiates the movement of the neurite cytoplasm towards the cell body, causing the neurite to form retraction bulbs, leaving observable thin trailing remnants along its retracted path. In our study, stabilization of F-actin with phalloidin completely blocked neurite retraction. There is increasing evidence that axon retraction is dependent on an interaction between myosin and actin. 5 6 The coordinated activation of myosin II and the formation of intra-axonal F-actin bundles for myosin II-driven force generation cause axon retraction. 5 The axonal microfilament system is subject to strong contractile forces generated by myosin, and those forces are counterbalanced by forces between the microfilament and microtubule arrays generated by cytoplasmic dynein. 6 Furthermore, retraction is regulated by a GTPase RhoA-dependent mechanism and negative regulation of RhoA and its downstream Rho-associated coiled coilforming protein kinase (ROCK) prevents the retraction of established axons in vivo. 15 In the cell, ROCK activated by the GTPase RhoA increases phosphorylation of myosin regulatory light chains by phosphorylating and inhibiting the myosin light chain (MLC) phosphatase. The motor protein myosin II is regulated by MLC kinase that directly phosphorylates myosin regulatory light chains. 16 A similar actin -myosin-dependent retraction has been observed for lysophosphatidic acid (LPA) in neurofilament rearrangements. 17 LPA is an extracellular signalling phospholipid that produces actin rearrangement to influence cell morphology and motility in various cell types, including neural and non-neural cells. 18 Retraction is an important function of individual neurones and neural plexuses during normal and pathological conditions and it has been shown that such an axon retraction pathway exists in developing 2 and mature neurones. 15 In our study, the concentration-dependent propofol retraction of neurites could be blocked by the GABA A R antagonist bicuculline. This demonstrates involvement of the GABA A R in propofol cell signalling. We have previously shown that propofol induces tyrosine phosphorylation in the GABA A R b 2 and b 3 -subtypes and increases the neuronal content of F-actin. 19 Our previous findings have demonstrated that propofol mediates a calciumdependent, reversible, and concentration-dependent actin reorganization. 10 When propofol was washed out 2 min after exposure, neurites continued to retract reaching a minimum length at 10 min. The continued retraction after propofol washout may be explained by the fact that it takes time to reverse the retraction process, a time that is similar to recovery after propofol anaesthesia. By 20 min, the neurites had returned to pretreatment length. We believe that the time scale is not dissimilar from that of clinical anaesthesia. There is a significant retraction of neurites after 1 and 2 min; it takes at least 2 min for patients to fall asleep when given propofol. The recovery period for patients after propofol anaesthesia is also within the timeframe we have seen (minutes, not seconds or hours). It must be taken into account that clearance by blood flow is more rapid than found in our Petri dish.
In line with our findings, Al-Jahdari and colleagues 9 recently reported that propofol at 5 and 20 mM concentrations induce mild growth cone collapse in chickembryonic neurones.
With support from previous studies, we suggest a signalling pathway leading to cytoskeletal rearrangement that involves a Rho pathway activation and MLC phosphorylation which increase the contractility of myosin, followed by reorganization of actin and neurite retraction. 15 The phenomenon of neurite retraction may explain the anaesthetic effect of propofol since neurite retraction has also been reported in hibernation 3 and neurotrauma. 4 Retraction of neurites in the cortex, thalamus, and hippocampus, together with decreased synaptic protein clustering without protein loss, has previously been shown in hibernating ground squirrels. 3 20 In the awake state, neurites returned to their pre-hibernation locations. 21 Several anaesthetic agents including propofol profoundly decrease ongoing neuronal activity in isolated cortical networks. 22 It has been shown that propofol and other anaesthetics modulate synaptic transmission 7 and depress neurosecretion. 8 At each synaptic contact, the magnitude of the postsynaptic response is related to the number of vesicles released and the amount of transmitter in each vesicle and alterations in receptor properties. In this study, we have shown that retracted neurites left a retraction bulb and a thin trailing remnant, which probably serve as a pathway for the neurite to find its way back when the effects of propofol are gone. It is very likely that the existing neuronal network prevails during anaesthesia, which could explain the rapid recovery. Remaining electrophysical action potentials support our findings that there is still a contact between the neurones. Our hypothesis is that the trailing neurite remnants become too narrow to allow vesicles through to the synapse which leads to inhibition of neurotransmitter release.
The findings in this study are obtained from in vitro experiments, which may not faithfully replicate in vivo conditions. As always, extrapolation of data obtained from laboratory-based studies to the clinical setting is difficult.
In conclusion, using brain cortical neurone cultures, we have shown that propofol causes a concentration-and time-dependent reversible neurite retraction. This retraction is GABA A R-mediated and dependent on actin and myosin II. Furthermore, the concentrations and times to full retraction and recovery correspond to the anaesthetic effects of propofol.
